The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Young James F since year 2005.
The trader's CIK number is 1219864.
At the time of the last reporting, Young James F was the President, R&D of Novavax Inc .
(stock ticker symbol NVAX).
See this page for all insider trading activities at Novavax Inc .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2017-08-31 | NVAX | Novavax Inc | Sale | 175,000 | 1.06 | 184,800 |
| 2017-03-14 | NVAX | Novavax Inc | Sale | 100,000 | 1.39 | 139,000 |
| 2015-06-18 | NVAX | Novavax Inc | Sale | 50,000 | 9.47 | 473,600 |
| 2014-03-25 | NVAX | Novavax Inc | Buy | 25,000 | 4.47 | 111,850 |
| 2013-06-06 | NVAX | Novavax Inc | Buy | 100,000 | 1.91 | 191,000 |
| 2013-03-11 | NVAX | Novavax Inc | Buy | 100,000 | 2.03 | 202,999 |
| 2011-12-01 | NVAX | Novavax Inc | Buy | 200,000 | 1.46 | 292,000 |
| 2006-02-03 | MEDI | Medimmune Inc /de | Sale | 8,640 | 32.62 | 281,862 |
| 2006-02-03 | MEDI | Medimmune Inc /de | Option Ex | 8,640 | 2.75 | 23,760 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Young James F (President, R&D of Novavax Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.